Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Journal of Translational Medicine|August 12, 2015
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trialPaola Ulivi, Emanuela Scarpi, Alessandro Passardi, et al.Cancers|September 13, 2025
Integrating Radiomics and Artificial Intelligence (AI) in Stereotactic Body Radiotherapy (SBRT)/Stereotactic Radiosurgery (SRS): Predictive Tools for Tailored Cancer CareIlaria Morelli, Marco Banini, Daniela Greto, et al.American Journal of Clinical Pathology|March 18, 2009
EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitorsGiuliana Sartori, Alberto Cavazza, Alessandro Sgambato, et al.Therapeutic Advances in Medical Oncology|August 6, 2020
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trialElisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, et al.Cancers|August 7, 2021
From Distress Screening to Uptake: An Italian Multicenter Study of Cancer PatientsElena Meggiolaro, Silvia De Padova, Federica Ruffilli, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional StudyFrancesco Raspagliesi, Giorgio Bogani, Laura Matteucci, et al.Oncology Letters|February 13, 2016
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective studyIlaria Massa, Oriana Nanni, Massimo Guidoboni, et al.Oncotargets and Therapy|September 15, 2018
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Elena Orlandi, et al.Journal of Clinical Medicine|September 27, 2025
Enhancing Timeliness and Compliance of Osteoporosis Care in Oncology: Evidence from a Dedicated Bone Health ServiceWilliam Balzi, Valentina Danesi, Andrea Roncadori, et al.Gynecologic Oncology|October 11, 2022
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26)Domenica Lorusso, Sandro Pignata, Stefano Tamberi, et al.Pageof 9